Company: BDRX
Filing Date: 2025-05-12
Form Type: 424B3
Source: 0001214659-25-007341
Chunk: 105

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-05-12
Form: 424B3
Chunk 105
---
 of Ordinary Shares
issued to the selling shareholders at the Closing and the number of Ordinary Shares issued to the selling shareholders upon the exercise
of the warrants issued at the Closing and (ii) the maximum number of Ordinary Shares upon exercise of the related warrants, determined
as if the outstanding warrants were exercised in full as of the trading day immediately preceding the date this registration statement
was initially filed with the SEC, each as of the trading day immediately preceding the applicable date of determination and all subject
to adjustment as provided in the registration right agreement, without regard to any limitations on the exercise of the warrants.

Under the terms of the warrants, a selling
shareholder may not exercise the warrants to the extent such exercise would cause such selling shareholder, together with its affiliates
and attribution parties, to beneficially own a number of Ordinary Shares which would exceed 4.99% or 9.99%, as applicable, of our then
outstanding Ordinary Shares following such exercise, excluding for purposes of such determination Ordinary Shares issuable upon exercise
of such warrants which have not been exercised. The beneficial ownership limitation may be increased or decreased, provided that in no
event shall it exceed 9.99%, upon notice to us, provided that any increase in the beneficial ownership limitation shall not be effective
until 61 days following the receipt of such notice by us. The number of shares in the table below does not reflect this limitation. See
“Plan of Distribution.” The selling shareholders may sell all, some or none of their Ordinary Shares in this offering.
See “Plan of Distribution.”

| 70 |

| Name of Selling Shareholder                   |     | Number of Ordinary 
 Shares Owned Prior 
 to                 
 Offering **        |               |     | Maximum Number of  
 Ordinary Shares to 
 be Sold            
 Pursuant to this   
 Prospectus **      |             |     | Number of          
 Ordinary           
 Shares Owned After 
 Offering** (1)     |             |     | Percentage     
 of             
 Ordinary       
 Shares         
 Owned          
 after the      
 Offering (%)** 
 *              |     |
| Bigger Capital Fund, LP (2)                   |     |                    |   843,460,000 |     |                    | 425,520,000 |     |                    | 417,940,000 |     |                | 1.6 |
| Brio Capital Master Fund Ltd. (3)             |     |                    | 1,160,720,000 |     |                    | 851,060,000 |     |